Medico Intercontinental Limited

BSE:539938 Stock Report

Market Cap: ₹524.4m

Medico Intercontinental Management

Management criteria checks 2/4

Medico Intercontinental's CEO is Dilipkumar Shah, appointed in May 2019, has a tenure of 5.58 years. directly owns 10.74% of the company’s shares, worth ₹56.34M. The average tenure of the management team and the board of directors is 5.5 years and 5.7 years respectively.

Key information

Dilipkumar Shah

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.6yrs
CEO ownership10.7%
Management average tenure5.5yrs
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Dilipkumar Shah

5.6yrs

Tenure

Mr. Dilipkumar Bhogilal Shah has been Chief Executive Officer of Medico Intercontinental Limited since May 29, 2019. Mr. Shah has vast experience of more than 40 years in Pharma Business.

Leadership Team

NamePositionTenureCompensationOwnership
Samir Shah
MD & Directorno data₹6.00m44.33%
₹ 232.5m
Dilipkumar Shah
Chief Executive Officer5.6yrsno data10.74%
₹ 56.3m
Jay Shah
Chief Financial Officer5.3yrs₹719.65kno data
Puneeta Sharma
Company Secretary & Compliance Officer5.5yrs₹438.19kno data

5.5yrs

Average Tenure

Experienced Management: 539938's management team is seasoned and experienced (5.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Samir Shah
MD & Director6.3yrs₹6.00m44.33%
₹ 232.5m
Tanvi Shah
Non-Executive Chairman6.3yrsno datano data
Ankur Dave
Independent Director5.8yrsno datano data
Swati Shah
Non-Executive Director5.6yrsno datano data
Priyank Sancheti
Independent Director2.1yrsno datano data
Parshwa Shah
Independent Directorless than a yearno datano data

5.7yrs

Average Tenure

Experienced Board: 539938's board of directors are considered experienced (5.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 11:31
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medico Intercontinental Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution